Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by ...

A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a ...

A diagnosis of advanced prostate cancer affects more than just your physical health — it also takes a toll on your mental health. Research shows that nearly 1 in 5 people with prostate cancer ...

“Me encontraron càncer en la pròstata,” my father told me. “They found cancer in my prostate.” As a cancer researcher who knows very well about the high incidence and decreased survival rates of ...